BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37012147)

  • 1. Differences in VA and Non-VA Pulmonary Nodules: All Evaluations Are not Created Equal.
    New ML; Hirsch EA; Feser WJ; Malkoski SP; Garg K; Miller YE; Baron AE
    Clin Lung Cancer; 2023 Jul; 24(5):407-414. PubMed ID: 37012147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communication About the Probability of Cancer in Indeterminate Pulmonary Nodules.
    Maiga AW; Deppen SA; Massion PP; Callaway-Lane C; Pinkerman R; Dittus RS; Lambright ES; Nesbitt JC; Grogan EL
    JAMA Surg; 2018 Apr; 153(4):353-357. PubMed ID: 29261826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules.
    Li Y; Hu H; Wu Z; Yan G; Wu T; Liu S; Chen W; Lu Z
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of a Blood-Based Protein Biomarker Panel to the Classification of Indeterminate Pulmonary Nodules.
    Ostrin EJ; Bantis LE; Wilson DO; Patel N; Wang R; Kundnani D; Adams-Haduch J; Dennison JB; Fahrmann JF; Chiu HT; Gazdar A; Feng Z; Yuan JM; Hanash SM
    J Thorac Oncol; 2021 Feb; 16(2):228-236. PubMed ID: 33137463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Prediction Models for Identifying Malignancy in Pulmonary Nodules Detected via Low-Dose Computed Tomography.
    González Maldonado S; Delorme S; Hüsing A; Motsch E; Kauczor HU; Heussel CP; Kaaks R
    JAMA Netw Open; 2020 Feb; 3(2):e1921221. PubMed ID: 32058555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma.
    Mano R; Vertosick E; Sankin AI; Chevinsky MS; Larish Y; Jakubowski CD; Hötker AM; Hakimi AA; Sjoberg DD; Akin O; Russo P
    J Urol; 2015 Mar; 193(3):776-82. PubMed ID: 25241004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
    Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
    Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
    Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
    J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal lung cancer prediction convolutional neural network model improves the classification of indeterminate pulmonary nodules.
    Paez R; Kammer MN; Balar A; Lakhani DA; Knight M; Rowe D; Xiao D; Heideman BE; Antic SL; Chen H; Chen SC; Peikert T; Sandler KL; Landman BA; Deppen SA; Grogan EL; Maldonado F
    Sci Rep; 2023 Apr; 13(1):6157. PubMed ID: 37061539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Thoracic Research Evaluation and Treatment 2.0 Model: A Lung Cancer Prediction Model for Indeterminate Nodules Referred for Specialist Evaluation.
    Godfrey CM; Shipe ME; Welty VF; Maiga AW; Aldrich MC; Montgomery C; Crockett J; Vaszar LT; Regis S; Isbell JM; Rickman OB; Pinkerman R; Lambright ES; Nesbitt JC; Maldonado F; Blume JD; Deppen SA; Grogan EL
    Chest; 2023 Nov; 164(5):1305-1314. PubMed ID: 37421973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Patient With a Pulmonary Nodule: A Review.
    Mazzone PJ; Lam L
    JAMA; 2022 Jan; 327(3):264-273. PubMed ID: 35040882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.
    Tanner NT; Porter A; Gould MK; Li XJ; Vachani A; Silvestri GA
    Chest; 2017 Aug; 152(2):263-270. PubMed ID: 28115167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models to Estimate the Probability of Malignancy in Patients with Pulmonary Nodules.
    Choi HK; Ghobrial M; Mazzone PJ
    Ann Am Thorac Soc; 2018 Oct; 15(10):1117-1126. PubMed ID: 30272500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Lung Cancer Prediction Model "Stress Test": Assessment of Models' Performance in a High-Risk Prospective Pulmonary Nodule Cohort.
    Heideman BE; Kammer MN; Paez R; Swanson T; Godfrey CM; Low SW; Xiao D; Li TZ; Richardson JR; Knight MA; Shojaee S; Deppen SA; Lentz RJ; Grogan EL; Maldonado F
    CHEST Pulm; 2024 Mar; 2(1):. PubMed ID: 38737731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Pulmonary Nodules: Clinical Practice Consensus Guidelines for Asia.
    Bai C; Choi CM; Chu CM; Anantham D; Chung-Man Ho J; Khan AZ; Lee JM; Li SY; Saenghirunvattana S; Yim A
    Chest; 2016 Oct; 150(4):877-893. PubMed ID: 26923625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast-enhanced computed tomography for the diagnosis of solitary pulmonary nodules: a systematic review and meta-analysis.
    Weir-McCall JR; Joyce S; Clegg A; MacKay JW; Baxter G; Dendl LM; Rintoul RC; Qureshi NR; Miles K; Gilbert FJ
    Eur Radiol; 2020 Jun; 30(6):3310-3323. PubMed ID: 32060716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and management of solitary and multiple pulmonary nodules.
    Viggiano RW; Swensen SJ; Rosenow EC
    Clin Chest Med; 1992 Mar; 13(1):83-95. PubMed ID: 1582151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
    Li X; Zhang Q; Jin X; Cao L
    World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules.
    Tahvilian S; Kuban JD; Yankelevitz DF; Leventon D; Henschke CI; Zhu J; Baden L; Yip R; Hirsch FR; Reed R; Brown A; Muldoon A; Trejo M; Katchman BA; Donovan MJ; Pagano PC
    BMC Pulm Med; 2023 Jun; 23(1):193. PubMed ID: 37277788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a prediction model for malignant pulmonary nodules: A cohort study.
    Ren Z; Ding H; Cai Z; Mu Y; Wang L; Pan S
    Medicine (Baltimore); 2021 Dec; 100(51):e28110. PubMed ID: 34941053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.